These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30425468)

  • 1. Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD.
    Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3381-3387. PubMed ID: 30425468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
    Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
    Sarioglu N; Hismiogullari AA; Bilen C; Erel F
    Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
    Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
    Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients.
    Savchenko L; Mykytiuk M; Cinato M; Tronchere H; Kunduzova O; Kaidashev I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2569-2575. PubMed ID: 30197513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
    Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
    Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
    Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.
    Jin J; Yu W; Li S; Lu L; Liu X; Sun Y
    Medicine (Baltimore); 2016 Jul; 95(29):e4219. PubMed ID: 27442646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma netrin-1 level with inflammatory balance and comorbidities in patients with acute exacerbation of COPD.
    Kerget B; Afşin DE; Kerget F; Koçak AO; Aksakal A; Kızıltunç A; Araz Ö; Yılmazel Uçar E; Akgün M
    Tuberk Toraks; 2021 Mar; 69(1):30-38. PubMed ID: 33853303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic inflammatory profile of smokers with and without COPD].
    Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
    Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
    Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical characteristics, prognosis and influencing factors in patients with bronchiectasis-chronic obstructive pulmonary disease overlap syndrome: A prospective study for more than five years.
    Dai Z; Zhong Y; Cui Y; Ma Y; Zeng H; Chen Y
    J Glob Health; 2024 Jun; 14():04129. PubMed ID: 38940273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.